Coca-Cola Amatil Limited (ASX: CCL)- Coca-Cola 2018 Half Year result is out

Beverages pioneer Coca-Cola Amatil Limited reported increased statutory net profit after tax for the first half year ending 30 June 2018 to $158.1 million, showing an improvement of 12.8% on previous corresponding period. However, underlying NPAT was $178.8 million, down 5.9%.

While earnings performance was in line with company’s target to accelerate the reinvestment of cost savings in 2018, underlying EBIT plunged 4.9% to $297.5 million and underlying EPS declined by 1.6%.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

Mixed performance has been observed among the different segments of the group, where underlying EBIT of Australian beverages declined by 3.6%, Alcohol and Coffee marked a significant growth of 4.7% over the past 6 months. The group has shown positive signs in Australian Beverages with revenue growth and improved volume trajectory mainly driven by transition to Coca-Cola ‘No Sugar.’

Putting across an excellent performance in New Zealand and Fiji, the group posted statutory EBIT growth of 6.6% to $257.2 million and EPS growth of 17.8%.

The board has declared interim dividend of 21.0 cents per share for first half year of 2018 similar to 1H17, franked to 65%. This represents an underlying payout ratio of 85.0 per cent for the half year.

The group decided to bring forward approximately $40 million of reinvestment from the expected cost savings in 2019 and 2020.

Investors gave a thumps up to first half year results of the company as CCL share price surged 3.571% to $9.860 on Wednesday, 22 August 2018.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report